Showing 65,841 - 65,860 results of 108,614 for search '(( a point decrease ) OR ( 5 ((((we decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.73s Refine Results
  1. 65841

    Image 2_The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI.tif by Rida Rehman (11120838)

    Published 2024
    “…</p>Methods<p>A closed, blunt, weight-drop mild TBI protocol was employed. …”
  2. 65842

    Image_4_Differential Action of Reelin on Oligomerization of ApoER2 and VLDL Receptor in HEK293 Cells Assessed by Time-Resolved Anisotropy and Fluorescence Lifetime Imaging Microsco... by Paula Dlugosz (6400175)

    Published 2019
    “…Details of this pathway are still not fully understood since the participating components are highly variable and create a complex mixture of interacting molecules. Reelin is proteolytically processed resulting in five different fragments some of which carrying the binding site for two different but highly homologous receptors, apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR). …”
  3. 65843

    Image_3_Differential Action of Reelin on Oligomerization of ApoER2 and VLDL Receptor in HEK293 Cells Assessed by Time-Resolved Anisotropy and Fluorescence Lifetime Imaging Microsco... by Paula Dlugosz (6400175)

    Published 2019
    “…Details of this pathway are still not fully understood since the participating components are highly variable and create a complex mixture of interacting molecules. Reelin is proteolytically processed resulting in five different fragments some of which carrying the binding site for two different but highly homologous receptors, apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR). …”
  4. 65844
  5. 65845

    Image_3_Differential Action of Reelin on Oligomerization of ApoER2 and VLDL Receptor in HEK293 Cells Assessed by Time-Resolved Anisotropy and Fluorescence Lifetime Imaging Microsco... by Paula Dlugosz (6400175)

    Published 2019
    “…Details of this pathway are still not fully understood since the participating components are highly variable and create a complex mixture of interacting molecules. Reelin is proteolytically processed resulting in five different fragments some of which carrying the binding site for two different but highly homologous receptors, apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR). …”
  6. 65846

    Image_1_Differential Action of Reelin on Oligomerization of ApoER2 and VLDL Receptor in HEK293 Cells Assessed by Time-Resolved Anisotropy and Fluorescence Lifetime Imaging Microsco... by Paula Dlugosz (6400175)

    Published 2019
    “…Details of this pathway are still not fully understood since the participating components are highly variable and create a complex mixture of interacting molecules. Reelin is proteolytically processed resulting in five different fragments some of which carrying the binding site for two different but highly homologous receptors, apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR). …”
  7. 65847

    Table_1_Differential Action of Reelin on Oligomerization of ApoER2 and VLDL Receptor in HEK293 Cells Assessed by Time-Resolved Anisotropy and Fluorescence Lifetime Imaging Microsco... by Paula Dlugosz (6400175)

    Published 2019
    “…Details of this pathway are still not fully understood since the participating components are highly variable and create a complex mixture of interacting molecules. Reelin is proteolytically processed resulting in five different fragments some of which carrying the binding site for two different but highly homologous receptors, apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR). …”
  8. 65848

    Table 1_The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI.xlsx by Rida Rehman (11120838)

    Published 2024
    “…</p>Methods<p>A closed, blunt, weight-drop mild TBI protocol was employed. …”
  9. 65849

    Image_1_Differential Action of Reelin on Oligomerization of ApoER2 and VLDL Receptor in HEK293 Cells Assessed by Time-Resolved Anisotropy and Fluorescence Lifetime Imaging Microsco... by Paula Dlugosz (6400175)

    Published 2019
    “…Details of this pathway are still not fully understood since the participating components are highly variable and create a complex mixture of interacting molecules. Reelin is proteolytically processed resulting in five different fragments some of which carrying the binding site for two different but highly homologous receptors, apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR). …”
  10. 65850

    Image_2_Differential Action of Reelin on Oligomerization of ApoER2 and VLDL Receptor in HEK293 Cells Assessed by Time-Resolved Anisotropy and Fluorescence Lifetime Imaging Microsco... by Paula Dlugosz (6400175)

    Published 2019
    “…Details of this pathway are still not fully understood since the participating components are highly variable and create a complex mixture of interacting molecules. Reelin is proteolytically processed resulting in five different fragments some of which carrying the binding site for two different but highly homologous receptors, apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR). …”
  11. 65851

    Table_1_Differential Action of Reelin on Oligomerization of ApoER2 and VLDL Receptor in HEK293 Cells Assessed by Time-Resolved Anisotropy and Fluorescence Lifetime Imaging Microsco... by Paula Dlugosz (6400175)

    Published 2019
    “…Details of this pathway are still not fully understood since the participating components are highly variable and create a complex mixture of interacting molecules. Reelin is proteolytically processed resulting in five different fragments some of which carrying the binding site for two different but highly homologous receptors, apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR). …”
  12. 65852

    Table 2_The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI.docx by Rida Rehman (11120838)

    Published 2024
    “…</p>Methods<p>A closed, blunt, weight-drop mild TBI protocol was employed. …”
  13. 65853

    Image 1_The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI.tif by Rida Rehman (11120838)

    Published 2024
    “…</p>Methods<p>A closed, blunt, weight-drop mild TBI protocol was employed. …”
  14. 65854

    Image_4_Differential Action of Reelin on Oligomerization of ApoER2 and VLDL Receptor in HEK293 Cells Assessed by Time-Resolved Anisotropy and Fluorescence Lifetime Imaging Microsco... by Paula Dlugosz (6400175)

    Published 2019
    “…Details of this pathway are still not fully understood since the participating components are highly variable and create a complex mixture of interacting molecules. Reelin is proteolytically processed resulting in five different fragments some of which carrying the binding site for two different but highly homologous receptors, apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR). …”
  15. 65855

    Image_2_Differential Action of Reelin on Oligomerization of ApoER2 and VLDL Receptor in HEK293 Cells Assessed by Time-Resolved Anisotropy and Fluorescence Lifetime Imaging Microsco... by Paula Dlugosz (6400175)

    Published 2019
    “…Details of this pathway are still not fully understood since the participating components are highly variable and create a complex mixture of interacting molecules. Reelin is proteolytically processed resulting in five different fragments some of which carrying the binding site for two different but highly homologous receptors, apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR). …”
  16. 65856

    Ethanol dependent phenotype of dopaminergic pathway mutants. by Pratima Pandey (8734935)

    Published 2021
    “…Please note that although we did not find a significant difference between WT and <i>dop-1</i> animals in this experiment, we did however find a significant decrease in the number of body bends seen in <i>dop-1</i> mutants that were outcrossed more times. …”
  17. 65857
  18. 65858

    DataSheet_1_Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set.docx by Hengrui Liu (2059750)

    Published 2022
    “…On the contrary, KIRC might have a lower cuproptosis activity because of the decrease in copper cell death gene expression. …”
  19. 65859

    Projection-resolved optical coherence tomography angiography (PR-OCTA) of hard exudates. by Alaa E. Fayed (6703916)

    Published 2019
    “…There is gradual decrease in the flow signal intensity with increasing PR-OCTA threshold from 0.3 to 0.5 (yellow ellipses), manifested by a decrease in red pixel percentage from 38.4% to 34.5%. …”
  20. 65860

    Bioluminescent imaging: mean Total flux (P/sec)± SD for X29, X31 and sterile implant. by Nis Pedersen Jørgensen (639380)

    Published 2014
    “…<p>2 minutes high sensitivity measurement of 1,5 cm<sup>2</sup> ROI. Xen 29 demonstrates a steady decrease in total photon flux, from 6.6×10<sup>6</sup> P/sec to 1.5×10<sup>4</sup> P/sec by day 15, which correspond to the levels seen in negative controls. …”